Beacon Hospital
- Address
- lock Available on a paid plan
Medical Oncology in Beacon Hospital
Clinical research here is focused on neoplasms, with a strong emphasis on breast cancer and breast neoplasms. The studies are designed to help improve treatment options for people with early-stage disease and a higher risk of recurrence, while also exploring ways to better control long-term outcomes.
- Testing new endocrine therapy approaches for ER-positive, HER2-negative breast cancer
- Evaluating whether treatment can reduce the risk of recurrence and distant spread in early breast cancer
At this Dublin site, the work is centered on comparing promising therapies with current standard care to see which options may offer better protection against disease progression.
Breast Cancer Research
The trial portfolio includes studies in oncology that focus on ER+/HER2- breast cancer, especially cases where disease markers suggest a risk of relapse. These trials aim to improve how clinicians prevent metastasis and manage early disease more effectively.
- Assessing imlunestrant against standard adjuvant therapy in early breast cancer
- Studying elacestrant for its potential to delay distant metastasis or death
The research at Beacon Hospital is part of a broader effort to refine breast cancer treatment and support more personalized care for patients with early-stage disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 45 other sites in Ireland
Therapeutic Area Benchmark — Ireland
Select a therapeutic area to compare against other sites in Ireland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Ireland
Market Share
Country: Ireland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Beacon Hospital
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| EORTC 2129-BCG: Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse (TREAT ctDNA) | Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi | Phase III | Recruiting | Feb 2024 | — |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 2 | Unknown | 2025-06-12 | 2025-07-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.